Literature DB >> 16972080

Microcephaly and simplified gyral pattern of the brain associated with early onset insulin-dependent diabetes mellitus.

M C Y de Wit1, I F M de Coo, C Julier, M Delépine, M H Lequin, I van de Laar, B J Sibbles, G J Bruining, G M S Mancini.   

Abstract

Two families are presented with a child suffering from microcephaly with a simplified gyral pattern of the brain (SGP) and early onset insulin dependent diabetes mellitus (IDDM). The first patient was diagnosed postmortally with Wolcott-Rallison syndrome, after her younger brother developed IDDM, and a homozygous mutation in the eukaryotic translation initiation factor 2-alpha kinase 3 was found. The younger brother did not undergo magnetic resonance imaging (MRI). The patient from the second family has no EIF2AK3 mutation. SGP is considered to arise from decreased neuronal proliferation or increased apoptosis at an early stage of embryonal development, but insight into the pathways involved is minimal. EIF2AK3 is involved in translation initiation. It has been proposed that loss of function mutations reduce the ability of the cell to respond to endoplasmic reticulum stress, resulting in apoptosis of pancreatic Langerhans cells. Our findings suggest that in some cases, early onset IDDM and SGP can arise from common mechanisms leading to increased apoptosis.

Entities:  

Mesh:

Year:  2006        PMID: 16972080     DOI: 10.1007/s10048-006-0061-1

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  16 in total

1.  EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome.

Authors:  M Delépine; M Nicolino; T Barrett; M Golamaully; G M Lathrop; C Julier
Journal:  Nat Genet       Date:  2000-08       Impact factor: 38.330

Review 2.  A developmental and genetic classification for malformations of cortical development.

Authors:  A J Barkovich; R I Kuzniecky; G D Jackson; R Guerrini; W B Dobyns
Journal:  Neurology       Date:  2005-09-28       Impact factor: 9.910

Review 3.  Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism.

Authors:  Anna L Gloyn; Juveria Siddiqui; Sian Ellard
Journal:  Hum Mutat       Date:  2006-03       Impact factor: 4.878

4.  PERK is responsible for the increased phosphorylation of eIF2alpha and the severe inhibition of protein synthesis after transient global brain ischemia.

Authors:  Cheri R Owen; Rita Kumar; Peichuan Zhang; Barbara C McGrath; Douglas R Cavener; Gary S Krause
Journal:  J Neurochem       Date:  2005-07-05       Impact factor: 5.372

5.  Uncharged tRNA and sensing of amino acid deficiency in mammalian piriform cortex.

Authors:  Shuzhen Hao; James W Sharp; Catherine M Ross-Inta; Brent J McDaniel; Tracy G Anthony; Ronald C Wek; Douglas R Cavener; Barbara C McGrath; John B Rudell; Thomas J Koehnle; Dorothy W Gietzen
Journal:  Science       Date:  2005-03-18       Impact factor: 47.728

Review 6.  Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and beta cell failure.

Authors:  J R Porter; T G Barrett
Journal:  J Med Genet       Date:  2005-03-16       Impact factor: 6.318

Review 7.  Autosomal recessive primary microcephaly (MCPH): a review of clinical, molecular, and evolutionary findings.

Authors:  C Geoffrey Woods; Jacquelyn Bond; Wolfgang Enard
Journal:  Am J Hum Genet       Date:  2005-03-31       Impact factor: 11.025

8.  The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas.

Authors:  Peichuan Zhang; Barbara McGrath; Sheng'ai Li; Ami Frank; Frank Zambito; Jamie Reinert; Maureen Gannon; Kun Ma; Kelly McNaughton; Douglas R Cavener
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

Review 9.  Wolcott-Rallison syndrome: a clinical and genetic study of three children, novel mutation in EIF2AK3 and a review of the literature.

Authors:  S Iyer; M Korada; L Rainbow; J Kirk; R M Brown; N Shaw; T G Barrett
Journal:  Acta Paediatr       Date:  2004-09       Impact factor: 2.299

10.  Phosphorylation of the alpha subunit of translation initiation factor-2 by PKR mediates protein synthesis inhibition in the mouse brain during status epilepticus.

Authors:  Larissa S Carnevalli; Catia M Pereira; Carolina B Jaqueta; Viviane S Alves; Vanessa N Paiva; Krishna M Vattem; Ronald C Wek; Luiz Eugênio A M Mello; Beatriz A Castilho
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

View more
  14 in total

1.  Microcephaly with simplified gyration, epilepsy, and infantile diabetes linked to inappropriate apoptosis of neural progenitors.

Authors:  Cathryn J Poulton; Rachel Schot; Sima Kheradmand Kia; Marta Jones; Frans W Verheijen; Hanka Venselaar; Marie-Claire Y de Wit; Esther de Graaff; Aida M Bertoli-Avella; Grazia M S Mancini
Journal:  Am J Hum Genet       Date:  2011-08-12       Impact factor: 11.025

2.  Exome sequencing can improve diagnosis and alter patient management.

Authors:  Stacey B Gabriel; Joseph G Gleeson; Tracy J Dixon-Salazar; Jennifer L Silhavy; Nitin Udpa; Jana Schroth; Stephanie Bielas; Ashleigh E Schaffer; Jesus Olvera; Vineet Bafna; Maha S Zaki; Ghada H Abdel-Salam; Lobna A Mansour; Laila Selim; Sawsan Abdel-Hadi; Naima Marzouki; Tawfeg Ben-Omran; Nouriya A Al-Saana; F Müjgan Sonmez; Figen Celep; Matloob Azam; Kiley J Hill; Adrienne Collazo; Ali G Fenstermaker; Gaia Novarino; Naiara Akizu; Kiran V Garimella; Carrie Sougnez; Carsten Russ
Journal:  Sci Transl Med       Date:  2012-06-13       Impact factor: 17.956

3.  Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families.

Authors:  Oscar Rubio-Cabezas; Ann-Marie Patch; Jayne A L Minton; Sarah E Flanagan; Emma L Edghill; Khalid Hussain; Amina Balafrej; Asma Deeb; Charles R Buchanan; Ian G Jefferson; Angham Mutair; Andrew T Hattersley; Sian Ellard
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

Review 4.  Wolcott-Rallison syndrome.

Authors:  Cécile Julier; Marc Nicolino
Journal:  Orphanet J Rare Dis       Date:  2010-11-04       Impact factor: 4.123

Review 5.  Imaging of the brain in children with type I diabetes mellitus.

Authors:  Sandra L Wootton-Gorges; Nicole S Glaser
Journal:  Pediatr Radiol       Date:  2007-07-10

6.  Microcephaly, epilepsy, and neonatal diabetes due to compound heterozygous mutations in IER3IP1: insights into the natural history of a rare disorder.

Authors:  Stavit A Shalev; Yardena Tenenbaum-Rakover; Yoseph Horovitz; Veronica P Paz; Honggang Ye; David Carmody; Heather M Highland; Eric Boerwinkle; Craig L Hanis; Donna M Muzny; Richard A Gibbs; Graeme I Bell; Louis H Philipson; Siri Atma W Greeley
Journal:  Pediatr Diabetes       Date:  2013-10-21       Impact factor: 4.866

7.  A homozygous IER3IP1 mutation causes microcephaly with simplified gyral pattern, epilepsy, and permanent neonatal diabetes syndrome (MEDS).

Authors:  Ghada M H Abdel-Salam; Ashleigh E Schaffer; Maha S Zaki; Tracy Dixon-Salazar; Inas S Mostafa; Hanan H Afifi; Joseph G Gleeson
Journal:  Am J Med Genet A       Date:  2012-09-18       Impact factor: 2.802

8.  New recessive syndrome of microcephaly, cerebellar hypoplasia, and congenital heart conduction defect.

Authors:  Maha S Zaki; Ghada M H Abdel Salam; Sahar N Saleem; William B Dobyns; Mahmoud Y Issa; Shifteh Sattar; Joseph G Gleeson
Journal:  Am J Med Genet A       Date:  2011-10-14       Impact factor: 2.802

9.  Wolcott-Rallison syndrome due to a novel mutation (R491X) in EIF2AK3 gene.

Authors:  Ercan Mihci; Doğa Türkkahraman; Sian Ellard; Sema Akçurin; Iffet Bircan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-06

10.  Monogenic and syndromic diabetes due to endoplasmic reticulum stress.

Authors:  Stephen I Stone; Damien Abreu; Janet B McGill; Fumihiko Urano
Journal:  J Diabetes Complications       Date:  2020-05-08       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.